Stefan Burdach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stefan Burdach has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Wechselberger
Children's Hospital Medical Center, University of Technology, Munich, Germany
1 shared publication - Anna Henger
Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA
1 shared publication - Irene von Luettichau
Children's Hospital Medical Center, University of Technology, Munich, Germany
1 shared publication - Marcus Kremer
Institute of Pathology, Technische Universitaet, Muenchen, Germany
1 shared publication - Michaela Nathrath
Technische Universität München, Munich, Germany
1 shared publication - Mike Notohamiprodjo
Department of Clinical Radiology, University Hospitals Munich, Marchioninistrasse 15, 81377 Munich, Germany
1 shared publication
Latest Publications
- Open Access
- 24 January 2008
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 23
A complex pattern of chemokine receptor expression is seen in osteosarcoma
Osteosarcoma is the most frequent bone tumor in childhood and adolescence. Patients with primary metastatic disease have a poor prognosis. It is therefore important to better characterize the biology of this tumor to define new prognostic markers or therapeutic targets for tailored therapy. Chemokines and their receptors have been shown to be involved in the development and progression of malignant tumors. They are thought to be active participants in the biology of osteosarcoma. The function of specific chemokines and their receptors is strongly associated with the biological context and microenvironment of their expression. In this report we characterized the expression of a series of chemokine receptors in the complex environment that defines osteosarcoma.
- 24 January 2008
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 23
Open AccessA complex pattern of chemokine receptor expression is seen in osteosarcoma
Osteosarcoma is the most frequent bone tumor in childhood and adolescence. Patients with primary metastatic disease have a poor prognosis. It is therefore important to better characterize the biology of this tumor to define new prognostic markers or therapeutic targets for tailored therapy. Chemokines and their receptors have been shown to be involved in the development and progression of malignant tumors. They are thought to be active participants in the biology of osteosarcoma. The function of specific chemokines and their receptors is strongly associated with the biological context and microenvironment of their expression. In this report we characterized the expression of a series of chemokine receptors in the complex environment that defines osteosarcoma.